Achieve Life Sciences

ACHVNasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$682.683 M

$6.65 +1.53%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$54.6M

Loss-making

Shares outstanding

53,239,988

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances — ranked by market cap

All 19 →

#7Anbio BiotechnologyNNNN$1.53B
#8QuidelOrthoQDEL$837.7M
#9Achieve Life SciencesACHV$682.7M
#10Alpha TeknovaTKNO$346.3M
#11Myriad GeneticsMYGN$311.8M

Where these numbers come from

Share counts and financials for Achieve Life Sciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.